This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Why J.C.Penney's (JCP) Cash Position Looks Shaky: Sterne Agee

Stocks in this article: JCP

NEW YORK (TheStreet) -- Sterne Agee has placed J.C.Penney's (JCP) liquidity position under the microscope and found the embattled retailer's cash situation worrisome, so much so it has suspended its $3 price target.

The move comes nearly a week after institutional investors Hotchkis & Wiley, Dodge & Cox and Hayman Capital withdrew their positions in the retailer. Another, Evercore Trust, lowered its stake to 4.12% from 5.33%.

Sterne Agee's Charles Grom, Renato Basanta and John Parke said while they expect a sales turnaround, the company will likely run into cash concerns within a few quarters at the current pace of recovery.

"Our base case currently incorporates a 2% comp in FY14 and a potentially generous gross profit margin recovery to 35.5%, but this still results in ~$800 million in cash burn, including ~$1.26 billion burn through 3Q14's peak seasonal inventory build," the analysts wrote in the report.

"As a result, cash levels fall to very low sub $250 million levels in 3Q14, which we believe may be too tight for vendors' comfort."

Sterne Agee sees additional cash burn of around $1.2 billion through to the October-ending third quarter of fiscal 2015, despite around 3% comparable store growth. Such a rate of spending will likely require another capital raise, something the company should consider sooner than later.

"We estimate the company may need a $500-$750 million liquidity infusion given the current pace of sales/margin recovery," said the analysts.

The Plano, Texas-based retailer has continued to see comps down around 7% through 2013, albeit at a less drastic decline than 2012's 25.3% drop. The company's most recent third quarter marked the seventh consecutive period of negative EBITDA. In the period ended October last year, the company posted an EBITDA loss of $218 million and a per-share earnings loss of $1.85.

The analysts anticipate full-year cash burn of $2.7 billion, including a net loss of $1.8 billion and capital expenses of $990 million.

In order to maintain liquidity, the analysts note there are options, though limited. These include raising $500 million in debt through a term loan, selling peripheral assets such as its 240 acres of real estate, monetizing below-market leases, or issuing additional equity (a last resort measure).

The investment firm notes the route to positive free cash flow will occur once a "significant change in comp trajectory" takes hold.

"Sales per square foot likely need to be 25% + above trough 2013 levels with gross profit margins in the 36-37% range and SG&A per square foot growth of only ~3%-6% vs. 2013. Importantly, we still view this as achievable, but believe the pace of recovery needs to accelerate soon, particularly given the weather/macro headwinds we are seeing throughout retail," the analysts wrote.

Until the firm receives greater detail on J.C.Penney's recovery, Sterne Agee has suspended its $3 price target, but retains a "neutral" rating. The analysts anticipate a fourth-quarter and full-year net loss of 36 cents and $3.72 a share, respectively.

J.C.Penney is due to report its fourth quarter and fiscal 2014 after the bell on Wednesday, Feb. 26.

Analysts surveyed by Thomson Reuters anticipate a net loss of 82 cents a share on $3.86 billion in sales. For the full year, consensus is for a net loss of $6.11 a share on $11.93 billion in sales.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs